Provectus Pharmaceuticals Inc. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Provectus Pharmaceuticals Inc.

PVCT 0.0650

0.0%

Nov 14 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: NTTG who wrote (12230)	7/15/2013 11:56:24 AM
From: mplaut	Read Replies (2) of 13111

This is not my list. It is the list covered by Dr Andtbacka in March of this year. At the beginning he discloses that he participated in the trials and/or advised on T-Vec and Allovectin-7. He makes no disclosures about PV-10 or PVCT so that would imply that he is not on their payroll in any way. I would greatly appreciate it if you would explain why the list is apples and oranges. Also, which are the other agents that are directly cytotoxic to tumor cells? (I will confess that I had to look up cytotoxic, but it certainly describes PV-10.) Where can we see how they performed? If they performed better, as you imply, then they are certainly worth a look.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next